-
Folate Therapy and In-Stent Restenosis and Coronary Stenting; Quinapril Reduces Markers of Oxidative Stress in the Metabolic Syndrome; Donepezil in Patients with Alzheimers
-
The FDA has approved a low dose estradiol transdermal patch for prevention of osteoporosis in menopausal women.
-
Esophageal adenocarcinoma (EAC), GERD, and Barretts esophagus (BE) are all on the rise, and there is no doubt that BE is a major risk factor for EAC. However, many unanswered questions surround screening GERD patients for BE and cancer.
-
Physical symptoms are quite common among patients with depression. These symptoms tend to improve during the first month of therapy with serotonin-antagonists. Most symptoms will plateau in months to follow.
-
FDA has approved a long-acting implant for the palliative treatment of prostate cancer.
-
Studies on HCV infection resolution show that PBMC HCV-RNA may remain, despite clearance of the virus from plasma.
-
Exenatide (Extendin-4) significantly lowered HbA1C and caused weight loss in type 2 diabetes patients.
-
Night sweats, day sweats, and hot flashes occur frequently in the elderly and are more closely associated with common ailments than serious illnesses.
-
The consequences of sleep deprivation, as measured in otherwise healthy men, include elevations of sympathetic activity, increased levels of cortisol, and altered glucose metabolism.
-
Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surgery. A substantial majority of patients with diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea experienced complete resolution or improvement.
